Claritev Corporation (NYSE: CTEV) Stock Competitors & Peer Comparison
See CTEV's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for CTEV and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CTEV | $29.48 | -4.16% | 517.5M | -2.33 | -$13.04 | N/A |
| VEEV | $199.10 | +0.88% | 31.7B | 23.46 | $8.33 | N/A |
| GEHC | $63.02 | -4.08% | 28.7B | 13.83 | $4.56 | +0.22% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $71.92 | +5.52% | 13.9B | 57.01 | $1.24 | N/A |
| BTSGU | $238.42 | +4.25% | 13.5B | 209.36 | $1.11 | N/A |
| TEM | $48.02 | -10.39% | 9.2B | -104.94 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $98.71 | +3.83% | 8.3B | 23.06 | $4.28 | N/A |
| HNGE | $87.81 | +2.13% | 6.7B | 44.66 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
CTEV vs VEEV Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, VEEV has a market cap of 31.7B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while VEEV trades at $199.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas VEEV's P/E ratio is 23.46. In terms of profitability, CTEV's ROE is +2.06%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, CTEV is less volatile compared to VEEV. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
CTEV vs GEHC Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, GEHC has a market cap of 28.7B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while GEHC trades at $63.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas GEHC's P/E ratio is 13.83. In terms of profitability, CTEV's ROE is +2.06%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, CTEV is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
CTEV vs GEHCV Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas GEHCV's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, CTEV is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
CTEV vs BTSG Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, BTSG has a market cap of 13.9B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while BTSG trades at $71.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas BTSG's P/E ratio is 57.01. In terms of profitability, CTEV's ROE is +2.06%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, CTEV is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
CTEV vs BTSGU Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, BTSGU has a market cap of 13.5B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while BTSGU trades at $238.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas BTSGU's P/E ratio is 209.36. In terms of profitability, CTEV's ROE is +2.06%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, CTEV is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
CTEV vs TEM Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, TEM has a market cap of 9.2B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while TEM trades at $48.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas TEM's P/E ratio is -104.94. In terms of profitability, CTEV's ROE is +2.06%, compared to TEM's ROE of -0.70%. Regarding short-term risk, CTEV is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
CTEV vs SGFY Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SGFY's P/E ratio is 70.91. In terms of profitability, CTEV's ROE is +2.06%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, CTEV is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
CTEV vs HQY Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while HQY trades at $98.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas HQY's P/E ratio is 23.06. In terms of profitability, CTEV's ROE is +2.06%, compared to HQY's ROE of +0.11%. Regarding short-term risk, CTEV is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
CTEV vs HNGE Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while HNGE trades at $87.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas HNGE's P/E ratio is 44.66. In terms of profitability, CTEV's ROE is +2.06%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, CTEV is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
CTEV vs RCM Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, RCM has a market cap of 6B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas RCM's P/E ratio is -102.21. In terms of profitability, CTEV's ROE is +2.06%, compared to RCM's ROE of +0.00%. Regarding short-term risk, CTEV is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
CTEV vs TXG Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, TXG has a market cap of 5.6B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while TXG trades at $43.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas TXG's P/E ratio is -257.29. In terms of profitability, CTEV's ROE is +2.06%, compared to TXG's ROE of -0.03%. Regarding short-term risk, CTEV is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
CTEV vs DOCS Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, DOCS has a market cap of 4B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while DOCS trades at $21.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas DOCS's P/E ratio is 14.07. In terms of profitability, CTEV's ROE is +2.06%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, CTEV is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
CTEV vs ONEM Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas ONEM's P/E ratio is -7.77. In terms of profitability, CTEV's ROE is +2.06%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, CTEV is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
CTEV vs PRVA Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, PRVA has a market cap of 3.4B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while PRVA trades at $26.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas PRVA's P/E ratio is 168.13. In terms of profitability, CTEV's ROE is +2.06%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, CTEV is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
CTEV vs PGNY Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while PGNY trades at $32.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas PGNY's P/E ratio is 23.31. In terms of profitability, CTEV's ROE is +2.06%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, CTEV is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
CTEV vs HTFL Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while HTFL trades at $24.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas HTFL's P/E ratio is -12.92. In terms of profitability, CTEV's ROE is +2.06%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, CTEV is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
CTEV vs WGS Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while WGS trades at $61.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas WGS's P/E ratio is 74.68. In terms of profitability, CTEV's ROE is +2.06%, compared to WGS's ROE of -0.28%. Regarding short-term risk, CTEV is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
CTEV vs TDOC Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while TDOC trades at $9.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas TDOC's P/E ratio is -10.47. In terms of profitability, CTEV's ROE is +2.06%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, CTEV is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
CTEV vs NXGN Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas NXGN's P/E ratio is -266.00. In terms of profitability, CTEV's ROE is +2.06%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, CTEV is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
CTEV vs OMDA Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while OMDA trades at $23.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas OMDA's P/E ratio is 338.57. In terms of profitability, CTEV's ROE is +2.06%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, CTEV is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
CTEV vs AGTI Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas AGTI's P/E ratio is -71.79. In terms of profitability, CTEV's ROE is +2.06%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, CTEV is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
CTEV vs GDRX Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while GDRX trades at $3.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas GDRX's P/E ratio is 9.52. In terms of profitability, CTEV's ROE is +2.06%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, CTEV is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
CTEV vs CERT Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while CERT trades at $6.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas CERT's P/E ratio is 17.77. In terms of profitability, CTEV's ROE is +2.06%, compared to CERT's ROE of -0.01%. Regarding short-term risk, CTEV is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
CTEV vs CCLDO Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas CCLDO's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, CTEV is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
CTEV vs HSTM Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, HSTM has a market cap of 845.5M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while HSTM trades at $28.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas HSTM's P/E ratio is 38.08. In terms of profitability, CTEV's ROE is +2.06%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, CTEV is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check HSTM's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
CTEV vs WGSWW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, WGSWW has a market cap of 748M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas WGSWW's P/E ratio is -0.02. In terms of profitability, CTEV's ROE is +2.06%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, CTEV is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check WGSWW's competition here
Phreesia, Inc. (NYSE: PHR)
CTEV vs PHR Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, PHR has a market cap of 662M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while PHR trades at $10.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas PHR's P/E ratio is 38.25. In terms of profitability, CTEV's ROE is +2.06%, compared to PHR's ROE of +0.03%. Regarding short-term risk, CTEV is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check PHR's competition here
Evolent Health, Inc. (NYSE: EVH)
CTEV vs EVH Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, EVH has a market cap of 652.4M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while EVH trades at $5.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas EVH's P/E ratio is 580.00. In terms of profitability, CTEV's ROE is +2.06%, compared to EVH's ROE of -0.78%. Regarding short-term risk, CTEV is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check EVH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
CTEV vs MPLN-WT Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, CTEV is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
CTEV vs ACCD Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas ACCD's P/E ratio is -3.08. In terms of profitability, CTEV's ROE is +2.06%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, CTEV is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
CTEV vs SHCR Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SHCR's P/E ratio is -3.76. In terms of profitability, CTEV's ROE is +2.06%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, CTEV is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check SHCR's competition here
NRC Health (NASDAQ: NRC)
CTEV vs NRC Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, NRC has a market cap of 490.8M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while NRC trades at $21.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas NRC's P/E ratio is 26.56. In terms of profitability, CTEV's ROE is +2.06%, compared to NRC's ROE of +0.57%. Regarding short-term risk, CTEV is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
CTEV vs SOPH Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SOPH has a market cap of 403.5M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SOPH trades at $6.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SOPH's P/E ratio is -11.29. In terms of profitability, CTEV's ROE is +2.06%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, CTEV is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
CTEV vs SLGC Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SLGC's P/E ratio is -3.04. In terms of profitability, CTEV's ROE is +2.06%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, CTEV is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SLGC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
CTEV vs SLGCW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, CTEV's ROE is +2.06%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, CTEV is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SLGCW's competition here
TruBridge, Inc. (NASDAQ: TBRG)
CTEV vs TBRG Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas TBRG's P/E ratio is 9.37. In terms of profitability, CTEV's ROE is +2.06%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, CTEV is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
CTEV vs MPLN Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas MPLN's P/E ratio is -0.23. In terms of profitability, CTEV's ROE is +2.06%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, CTEV is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
CTEV vs SLP Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SLP trades at $18.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SLP's P/E ratio is 20.72. In terms of profitability, CTEV's ROE is +2.06%, compared to SLP's ROE of +0.06%. Regarding short-term risk, CTEV is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
CTEV vs TRHC Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas TRHC's P/E ratio is -4.27. In terms of profitability, CTEV's ROE is +2.06%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, CTEV is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
CTEV vs SMFR Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SMFR's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, CTEV is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
CTEV vs SPOK Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SPOK has a market cap of 222.2M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SPOK trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SPOK's P/E ratio is 17.73. In terms of profitability, CTEV's ROE is +2.06%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, CTEV is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check SPOK's competition here
So-Young International Inc. (NASDAQ: SY)
CTEV vs SY Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SY has a market cap of 220.4M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SY trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SY's P/E ratio is -5.09. In terms of profitability, CTEV's ROE is +2.06%, compared to SY's ROE of -0.16%. Regarding short-term risk, CTEV is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SY's competition here
American Well Corporation (NYSE: AMWL)
CTEV vs AMWL Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, AMWL has a market cap of 220.3M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while AMWL trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas AMWL's P/E ratio is -2.54. In terms of profitability, CTEV's ROE is +2.06%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, CTEV is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
CTEV vs HCAT Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, HCAT has a market cap of 166.3M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while HCAT trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas HCAT's P/E ratio is 11.25. In terms of profitability, CTEV's ROE is +2.06%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, CTEV is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
CTEV vs CPSI Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas CPSI's P/E ratio is -183.80. In terms of profitability, CTEV's ROE is +2.06%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, CTEV is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
CTEV vs OPRX Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, OPRX has a market cap of 125.5M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while OPRX trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas OPRX's P/E ratio is 6.14. In terms of profitability, CTEV's ROE is +2.06%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, CTEV is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
CTEV vs AUGX Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas AUGX's P/E ratio is -4.99. In terms of profitability, CTEV's ROE is +2.06%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, CTEV is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
CTEV vs CCLD Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, CCLD has a market cap of 98.6M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while CCLD trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas CCLD's P/E ratio is 8.59. In terms of profitability, CTEV's ROE is +2.06%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, CTEV is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
CTEV vs DH Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, DH has a market cap of 80.1M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while DH trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas DH's P/E ratio is 2.92. In terms of profitability, CTEV's ROE is +2.06%, compared to DH's ROE of -0.67%. Regarding short-term risk, CTEV is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
CTEV vs FORA Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas FORA's P/E ratio is -24.11. In terms of profitability, CTEV's ROE is +2.06%, compared to FORA's ROE of -0.17%. Regarding short-term risk, CTEV is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
CTEV vs CCLDP Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas CCLDP's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, CTEV is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
CTEV vs ONMD Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, ONMD has a market cap of 38.7M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while ONMD trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas ONMD's P/E ratio is -4.53. In terms of profitability, CTEV's ROE is +2.06%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, CTEV is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
CTEV vs SNCE Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SNCE's P/E ratio is -0.27. In terms of profitability, CTEV's ROE is +2.06%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, CTEV is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
CTEV vs AKLI Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas AKLI's P/E ratio is -0.71. In terms of profitability, CTEV's ROE is +2.06%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, CTEV is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
CTEV vs SHLT Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SHLT's P/E ratio is -3.87. In terms of profitability, CTEV's ROE is +2.06%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, CTEV is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
CTEV vs SHCRW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, CTEV's ROE is +2.06%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, CTEV is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
CTEV vs ONMDW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas ONMDW's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, CTEV is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
CTEV vs STRM Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas STRM's P/E ratio is -2.40. In terms of profitability, CTEV's ROE is +2.06%, compared to STRM's ROE of -0.32%. Regarding short-term risk, CTEV is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
CTEV vs RNLX Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas RNLX's P/E ratio is -0.33. In terms of profitability, CTEV's ROE is +2.06%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, CTEV is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
CTEV vs LIFW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas LIFW's P/E ratio is -0.02. In terms of profitability, CTEV's ROE is +2.06%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, CTEV is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check LIFW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
CTEV vs EUDA Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, EUDA has a market cap of 21.1M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while EUDA trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas EUDA's P/E ratio is -21.32. In terms of profitability, CTEV's ROE is +2.06%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, CTEV is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check EUDA's competition here
Babylon Holdings Limited (NYSE: BBLN)
CTEV vs BBLN Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas BBLN's P/E ratio is -0.04. In terms of profitability, CTEV's ROE is +2.06%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, CTEV is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
CTEV vs BEATW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, BEATW has a market cap of 13.4M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas BEATW's P/E ratio is -0.04. In terms of profitability, CTEV's ROE is +2.06%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, CTEV is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check BEATW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
CTEV vs ETAO Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas ETAO's P/E ratio is -0.01. In terms of profitability, CTEV's ROE is +2.06%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, CTEV is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
CTEV vs BFRG Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while BFRG trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas BFRG's P/E ratio is -1.20. In terms of profitability, CTEV's ROE is +2.06%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, CTEV is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check BFRG's competition here
Cue Health Inc. (NASDAQ: HLTH)
CTEV vs HLTH Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas HLTH's P/E ratio is -0.02. In terms of profitability, CTEV's ROE is +2.06%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, CTEV is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check HLTH's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
CTEV vs SCNX Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas SCNX's P/E ratio is -0.16. In terms of profitability, CTEV's ROE is +2.06%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, CTEV is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
CTEV vs UPH Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas UPH's P/E ratio is -0.07. In terms of profitability, CTEV's ROE is +2.06%, compared to UPH's ROE of -1.05%. Regarding short-term risk, CTEV is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
CTEV vs UPH-WT Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, CTEV is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check UPH-WT's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
CTEV vs MGRX Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, MGRX has a market cap of 4.2M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while MGRX trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas MGRX's P/E ratio is -0.31. In terms of profitability, CTEV's ROE is +2.06%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, CTEV is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
CTEV vs PEAR Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas PEAR's P/E ratio is -0.08. In terms of profitability, CTEV's ROE is +2.06%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, CTEV is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
CTEV vs PEARW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas PEARW's P/E ratio is -0.00. In terms of profitability, CTEV's ROE is +2.06%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, CTEV is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
CTEV vs OTRK Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas OTRK's P/E ratio is -0.02. In terms of profitability, CTEV's ROE is +2.06%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, CTEV is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check OTRK's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
CTEV vs VSEEW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, VSEEW has a market cap of 2.2M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while VSEEW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, CTEV's ROE is +2.06%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, CTEV is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check VSEEW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
CTEV vs HCTI Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, HCTI has a market cap of 2.1M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while HCTI trades at $1.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas HCTI's P/E ratio is -0.23. In terms of profitability, CTEV's ROE is +2.06%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, CTEV is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
CTEV vs CMAX Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas CMAX's P/E ratio is -0.00. In terms of profitability, CTEV's ROE is +2.06%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, CTEV is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
CTEV vs VSEE Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, VSEE has a market cap of 1.6M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while VSEE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas VSEE's P/E ratio is -0.19. In terms of profitability, CTEV's ROE is +2.06%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, CTEV is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
CTEV vs ACON Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while ACON trades at $2.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas ACON's P/E ratio is -0.24. In terms of profitability, CTEV's ROE is +2.06%, compared to ACON's ROE of -0.54%. Regarding short-term risk, CTEV is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
CTEV vs LIFWZ Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, CTEV is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check LIFWZ's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
CTEV vs EUDAW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, EUDAW has a market cap of 926.3K. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while EUDAW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, CTEV's ROE is +2.06%, compared to EUDAW's ROE of +0.70%. Regarding short-term risk, CTEV is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check EUDAW's competition here
SCWorx Corp. (NASDAQ: WORX)
CTEV vs WORX Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, WORX has a market cap of 693.4K. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while WORX trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas WORX's P/E ratio is -0.76. In terms of profitability, CTEV's ROE is +2.06%, compared to WORX's ROE of -0.65%. Regarding short-term risk, CTEV is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
CTEV vs MSPRZ Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, CTEV is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
CTEV vs KERN Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas KERN's P/E ratio is -0.01. In terms of profitability, CTEV's ROE is +2.06%, compared to KERN's ROE of -0.17%. Regarding short-term risk, CTEV is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
CTEV vs KERNW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas KERNW's P/E ratio is -0.00. In terms of profitability, CTEV's ROE is +2.06%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, CTEV is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
CTEV vs LIFWW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas LIFWW's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, CTEV is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
CTEV vs ZCMD Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, ZCMD has a market cap of 58K. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while ZCMD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, CTEV's ROE is +2.06%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, CTEV is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
CTEV vs CMAXW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas CMAXW's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, CTEV is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
CTEV vs ACONW Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, ACONW has a market cap of 11.7K. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas ACONW's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, CTEV is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check ACONW's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
CTEV vs MTBCO Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas MTBCO's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, CTEV is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check MTBCO's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
CTEV vs MSPRV Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas MSPRV's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to MSPRV's ROE of N/A. Regarding short-term risk, CTEV is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
CTEV vs MTBCP Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas MTBCP's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, CTEV is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
CTEV vs MTBC Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, MTBC has a market cap of 0. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas MTBC's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, CTEV is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check MTBC's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
CTEV vs CHNG Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, CHNG has a market cap of 0. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas CHNG's P/E ratio is -152.72. In terms of profitability, CTEV's ROE is +2.06%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, CTEV is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CHNG's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
CTEV vs CHNGU Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas CHNGU's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, CTEV is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CHNGU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
CTEV vs CNVY Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, CNVY has a market cap of 0. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas CNVY's P/E ratio is -71.50. In terms of profitability, CTEV's ROE is +2.06%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, CTEV is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CNVY's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
CTEV vs NAVA Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, NAVA has a market cap of 0. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas NAVA's P/E ratio is N/A. In terms of profitability, CTEV's ROE is +2.06%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, CTEV is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for CTEV.Check NAVA's competition here
Cerner Corporation (NASDAQ: CERN)
CTEV vs CERN Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, CERN has a market cap of 0. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas CERN's P/E ratio is 55.84. In terms of profitability, CTEV's ROE is +2.06%, compared to CERN's ROE of +0.14%. Regarding short-term risk, CTEV is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CERN's competition here
Castlight Health, Inc. (NYSE: CSLT)
CTEV vs CSLT Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, CSLT has a market cap of 0. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas CSLT's P/E ratio is -37.27. In terms of profitability, CTEV's ROE is +2.06%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, CTEV is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for CTEV.Check CSLT's competition here
NantHealth, Inc. (NASDAQ: NH)
CTEV vs NH Comparison July 2026
Claritev Corporation (NYSE: CTEV) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CTEV stands at 517.5M. In comparison, NH has a market cap of 0. Regarding current trading prices, CTEV is priced at $29.48 on the NYSE, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CTEV currently has a P/E ratio of -2.33, whereas NH's P/E ratio is -0.12. In terms of profitability, CTEV's ROE is +2.06%, compared to NH's ROE of +0.35%. Regarding short-term risk, CTEV is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for CTEV.Check NH's competition here